南模生物涨2.07%，成交额162.79万元

Group 1 - The core viewpoint of the articles highlights the recent stock performance and financial results of Nanmo Biological, indicating a slight increase in stock price and significant growth in revenue and net profit [1][2] - As of January 5, Nanmo Biological's stock price rose by 2.07% to 41.86 CNY per share, with a total market capitalization of 3.264 billion CNY [1] - The company has experienced a year-to-date stock price increase of 2.07%, with a 14.29% year-on-year revenue growth of 303 million CNY for the period from January to September 2025 [1] Group 2 - Nanmo Biological's main business involves the research, production, and sales of genetically modified animal models, with revenue contributions from standardized models (48.34%), model technical services (21.92%), breeding (19.50%), and customized models (9.34%) [1] - The company has distributed a total of 30.0413 million CNY in dividends since its A-share listing, with 10.0047 million CNY in the last three years [2] - As of September 30, 2025, the number of shareholders increased by 2.53% to 6,687, while the average circulating shares per person decreased by 2.47% to 11,658 shares [1]